Our Partners

Our Official Partners

Get in touch if you would like to partner with us and learn more about our bespoke sponsorship opportunities.

Expertise Partners

Almac

Almac has been supplying peptides to the research community and for clinical trials for 30 years. The field of personalized cancer vaccines required a new manufacturing paradigm to ensure high throughput manufacture of multiple neoantigens in an appropriate timescale to the required quality and regulatory standards. Almac has created a world leading offering to meet all of those demands, which can be tailored to meet specific client needs. Think Almac for peptide excellence.

www.almacgroup.com

4basebio

4basebio’s synthetic DNA technology is ideally suited for DNA and mRNA vaccine development and manufacturing. Timelines to large scale and GMP are greatly reduced compared to plasmid DNA, significantly accelerating the development of personalized or rapid response vaccines. Additionally, osDNA™ can be tuned to increase immunostimulatory properties, facilitating DNA vaccine dose reductions compared to plasmid DNA whilst eliciting an enhanced immune response. And oeDNA™ can be used as IVT template, directly linear and coding long continuous poly(A) tails, providing high yield of homogenous mRNA products.

www.4basebio.com

Nutcracker Therapeutics

Nutcracker Therapeutics, Inc. is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA platform that encompasses the design, delivery, and manufacturing of RNA medicines. Armed with this high-tech advantage, the company has initiated multiple therapeutic programs with the support of clinical investigators at leading institutions. Nutcracker Therapeutics’ technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in speed and capacity scaling over other RNA manufacturing approaches

www.nutcrackerx.com

Event Partners

Epitopea

Epitopea is a cancer immunotherapeutic company developing accessible off-the-shelf RNA-based immunotherapies. The company has identified novel aberrantly expressed tumor-specific antigens (aeTSA’s) that are hidden in non-canonical DNA, known as CryptigenTM TSAs, using its proprietary CryptoMapTM platform. These hidden CryptigenTM TSAs were first discovered through research led by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at the Université de Montréal.

Epitopea is backed by a syndicate of leading life science investors. For additional information, please visit www.epitopea.com and follow us on LinkedIn.

Foundation Medicine

Foundation Medicine is a pioneer in molecular profiling for cancer, working to shape the future of clinical care and research. We collaborate with a broad range of partners across the cancer community and strive to set the standard for quality, scientific excellence, and regulatory leadership. Our deep understanding of cancer biology helps physicians make informed treatment decisions for their patients and empowers researchers to develop new medicines. Every day, we are driven to help our partners find answers and take action, enabling more people around the world to benefit from precision cancer care.

www.foundationmedicine.com

Personalized Cancer Vaccines - individualized cancer vaccines

Beacon

LineaRx

LineaRx™, an Applied DNA Sciences, Inc. company, delivers enzymatically-produced Linea™ DNA as an
alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies. Produced using a proprietary, largescale polymerase chain reaction (“PCR”) based manufacturing platform, Linea DNA allows for the rapid and efficient cell-free production of high-fidelity DNA sequences.

www.linearxdna.com

*Formerly the mRNA Cancer Vaccine Summit

December 3-5, 2024
Boston, MA

Part of the World RNA Series

December 3-5, 2024
Boston, MA

Our Partners

Our Official Partners

Expertise Partners

Event Partners

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

*Formerly the mRNA Cancer Vaccine Summit

December 3-5, 2024 Boston, MA

Part of the World RNA Series

December 3-5, 2024 Boston, MA

Our Partners

Our Official Partners

Expertise Partners

Event Partners

VENUE

LOCATION

OUR CONTACT DETAILS

JOIN OUR TEAM

ABOUT US

EXPLORE OUR PRODUCTS

SEARCH

December 3-5, 2024
Boston, MA

December 3-5, 2024
Boston, MA